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Background: Sex hormones are known to regulate some responses during exercise. Evaluation of the differences in
exercise response with regard to menstrual cycle will help understand the menstrual cycle phase specific
adaptations to exercise and athletic performance.
Methods: We investigated the effects of menstrual cycle phase and carbohydrate (CHO) ingestion on immune
response during endurance exercise at 30°C. Six healthy women completed 4 trials comprising 90 min of cycling at
50% peak aerobic power _VO2peak
 
and a high intensity time trial performance test (POST). They ingested a
placebo- or CHO-containing beverage during the trials, which were performed during both the follicular and luteal
phases of the menstrual cycle. In all trials, thermoregulatory, cardiorespiratory, and immune responses were measured
during exercise and after POST.
Results: Although the thermoregulatory responses differed between the menstrual cycle phases, the cardiorespiratory
responses were not different. After placebo ingestion, leukocyte concentration (cells/μL) at POST (15.9 × 103) in the
luteal phase was significantly higher than that in the follicular phase (12.9 × 103). The rise in leukocyte concentration
was attenuated upon CHO ingestion, and the difference between menstrual cycle phases disappeared. A significant
positive correlation was found between leukocyte concentration and serum free fatty acid concentrations. Interleukin-6,
calprotectin, and myeloperoxidase concentrations significantly increased at POST in all trials, but no significant differences
were observed between menstrual cycle phase or beverage type. Concentrations of other cytokines did not change
during exercise in any of the 4 trials. Menstrual cycle phase and beverage type had no significant effect on the POST
outcome. Thus, differences in leukocyte mobilization between menstrual cycle phases could result from the effect of
sex hormones on substrate utilization.
Conclusions: The menstrual cycle affected circulating leukocyte concentrations during endurance exercise with POST
when a placebo was ingested. Therefore, we recommend ingesting CHO beverages to attenuate immune disturbances,
especially in the luteal phase, even though they are unlikely to enhance test performance.
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With an increase in the number of women participating
in sports for recreation, health, fitness, weight manage-
ment, social interaction, competition, and/or personal
accomplishment, the influence of menstrual cycle phase
on physiologic response to exercise has received much
attention, not only for athletes but also women in gen-
eral. Sex hormones are known to regulate substrate
utilization [1], muscle fatigue [2], temperature regulation
[3], and endocrine response [4] during exercise. Evalu-
ation of the differences in exercise response with regard
to menstrual cycle phase will help understand the men-
strual cycle phase–specific adaptations to exercise and
athletic performance.
A number of studies involving male subjects have re-
ported that exercise causes disturbances in circulating
leukocyte concentrations and function and that these ef-
fects are dependent on the intensity of exercise and the
associated release of stress hormones [5]. Furthermore,
body temperature has been shown to affect leukocyte
mobilization, cytokines, and markers of neutrophil acti-
vation during and after exercise in men. Thus, greater
systemic mobilization was observed in a hot environ-
ment [6,7].
In women with a normal menstrual cycle, core tem-
perature (Tc) rises by 0.3°–0.5°C in the luteal phase
compared to the follicular phase [8]. Therefore, we hy-
pothesized that a stressful condition (higher Tc and car-
diorespiratory strain) in the luteal phase would affect
immune response to prolonged exercise. Although sev-
eral studies have reported the effect of exercise on im-
mune response, very few have investigated the effect of
menstrual cycle phase. One study reported that men-
strual cycle phase did not significantly affect immune
cell response (leukocytes, monocytes, neutrophils, and
lymphocytes) after 90 min of cycling at 65% maximal
aerobic power [9], However, there was no information
on Tc during exercise, and it appeared that the concen-
tration of progesterone, which is involved in body tem-
perature regulation, was too low in the luteal phase.
Several studies have investigated the effect of men-
strual cycle phase on endurance exercise performance,
but consistent results have not been obtained [10,11].
One study showed that endurance performance was sig-
nificantly decreased during the luteal phase compared
with the follicular phase in a hot and humid condition
(32°C, 60% relative humidity), even though there was no
difference between menstrual cycle phases in a temper-
ate condition (20°C, 45% relative humidity) [12]. One
characteristic of that study was to set a strict progester-
one concentration (>5.1 ng/mL) as the criterion thresh-
old for definition of the luteal phase.
A number of previous studies involving male subjects
reported that CHO ingestion during exercise couldsuppress the mobilization of leukocytes into the circulation
[13-15] and secretion of cytokines [13,15-18]. Ingestion of
CHO during prolonged exercise, maintains blood glu-
cose concentration, lessens hypothalamic-pituitary-adrenal
activation and diminishes the perturbation of circulating
leukocyte concentration and function [19-21].
It is known that ovarian hormones can exert metabolic
actions affecting substrate utilization. For example, ad-
ministration of estradiol and progesterone in rats has
been reported to decrease gluconeogenesis from alanine
and to increase hepatic storage [22], and variations in
plasma ovarian hormones concentrations have been
shown to alter gluconeogenesis [23]. Furthermore, animal
studies show that larger lipid, and lower CHO, utilization
occurs during exercise when estrogen and progesterone,
are elevated [24,25]. Exercise substrate utilization in
women throughout menstrual cycle has generally been
characterized by the measurement of respiratory exchange
rate (RER). Although discrepancies occur when studying
RER in women at rest or during exercise, some data shows
the significant difference between the menstrual cycle
phases. Furthermore, previous research shows decrease of
blood glucose concentration in luteal phase compared to
follicular phase during prolonged exercise [26]. This low
blood glucose concentration in the luteal phase may have
a different impact on immune response between men-
strual phases during prolonged exercise.
The first purpose of our study was to examine the ef-
fect of menstrual cycle phase on immune response to
exercise in a hot condition, with a progesterone concen-
tration threshold for luteal phase verification. To our
knowledge, the interaction between exercise in a hot
condition and menstrual cycle phase with progesterone
limitation on immune response has not been systematic-
ally studied because the exercise conditions in previous
studies were not defined. The second purpose of our
study was to investigate the effect of CHO ingestion on
immune response. We hypothesized that menstrual cycle
may affect immune responses and that CHO ingestion
attenuates these effects.Materials and methods
Subjects
Six healthy young women volunteered to take part in
this study. All subjects maintained a regular menstrual
cycle and were not taking any oral contraceptives before
testing. Their mean characteristics were as follows: age,
23 (SD, 2.6) years; weight, 48.7 (SD, 6.1) kg; height,
156.2 (SD, 2.4) cm; and peak aerobic power _VO2peak
 
,
39.5 (SD, 5.3) mL/kg/min. Four subjects had not per-
formed regular physical activities for the previous 3 years,
whereas two other subjects performed regular physical
activities (e.g. swimming).
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This study comprised 4 separate experimental trials.
Subjects exercised in the condition (30 [SD, 2]°C and 50
[SD, 5]% relative humidity) during follicular and luteal
phases of their menstrual cycle. During the exercise,
subjects either consumed a CHO beverage containing
3.8% CHO (2.1% glucose and 1.7% fructose) or a placebo
sweetened with an artificial sweetener (sucralose and
acesulfame potassium) that tasted like the CHO bever-
age. We used a hypotonic CHO beverage (osmolality
195 mOsm/kg), which was reported to attenuate some
inflammatory responses to exercise [27]. The compo-
nents and ingredients of both beverages were otherwise
identical. The composition of both beverages was as
follows: protein and fat, 0 g/100 mL; sodium, 26 mg/
100 mL; potassium, 6 mg/100 mL; calcium, 1 mg/
100 mL;, and magnesium, 1 mg/100 mL. Both beverages
had the same flavor and color (slightly cloudy) and were
served to subjects in a transparent plastic cup. Thus,
subjects were blinded as to which beverage they were
consuming. Subjects were asked to ingest 300 mL of
either beverage 30 min before exercise and another
107 mL every 15 min during the 90-min exercise (7 times),
so that the total intake was 1,050 mL per participant. The
amount and timing of intake were determined according
to the position stands of the American College of Sports
Medicine [28]. This study was approved by the Human Re-
search Ethics Committee of the Faculty of Sport Sciences
of Waseda University for the use of human subjects in ac-
cordance with the Declaration of Helsinki. Prior to partici-
pation, each subject provided her informed consent.Preliminary testing
To estimate menstrual cycle phase, all subjects recorded
their oral temperature upon waking every day for at least
2 months and the day of menstruation for 3 months before
commencement of the trial. Additionally, blood samples
taken before commencement of the exercise were analyzed




was measured using a maximal graded ex-
ercise test with an electromagnetically braked cycle erg-
ometer (Combi RS-232; Combi, Tokyo, Japan). The
initial workload was 0 W for 4 min (warming up) and
was increased by 30 W every 3 min thereafter, starting at
40 W, until subjects could no longer maintain the re-
quired pedaling frequency (70 rpm). Heart rate (HR) was
monitored by electrocardiography (Cardiosuper 2E32;
Sanei-Sokki, Yamagata, Japan) throughout the exercise.
During the progressive exercise test, the expired gas of
subjects was collected, and the rates of oxygen con-
sumption _VO2
 
and carbon dioxide production _VCO2
were measured and averaged over 30-s intervals using anautomated breath-by-breath gas analyzer (Minato AE300;
Minato Medical Science, Osaka, Japan). _VO2peak was de-
fined as the highest 30-s value. At the end of each work-
load stage, subjects were asked to indicate the rating of
perceived exertion (RPE) by using the Borg Scale [29].Experimental trials
All subjects completed four separate experimental trials,
with each trial occurring at a specific time during the
menstrual cycle, previously determined for each subject
by her basal body temperature. For the 2 CHO and 2
placebo trials, 1 trial each occurred in the follicular
phase (FC and FA, respectively), and 1 trial each in the
luteal phase (LC and LA, respectively). To avoid a con-
founding phase and beverage effect with trial order,
subjects were randomly assigned trial orders, with 3 sub-
jects commencing in the follicular phase and 3 in the lu-
teal phase. Each experimental trial was performed on a
separate day at least 1 week apart. Subjects were asked
to only drink water after 21:00 h on the day before the
experimental trial, and they ate a standardized breakfast
(protein, 12.4 g; fat, 5.5 g; CHO, 75.7 g; and total energy,
395 kcal) at 06:00 h, i.e. 6–7 h before each trial. There-
after, foods and beverages, except for water, were not
allowed.
In all 4 trials, subjects cycled at 50% _VO2peak (60 [SD,
12.2] W) for 90 min in a hot condition (30 [SD, 2]°C and
50 [SD, 5]% relative humidity) and completed POST.
The workload corresponding to 50% _VO2peak was deter-
mined from the graded exercise test by interpolation
from the line of the best fit describing the relationship
between power output and _VO2. During endurance sports
competitions, such as marathons, many participants at-
tempt sprints in the final stage of the race. Therefore,
in order to simulate an actual competition, our experi-
mental protocol comprised of 2 parts: 90 min of cycling
exercise at moderate intensity and a timed performance
test. This study composed of a prolonged exercise and
performance test under hot condition by untrained sub-
jects. We set exercise intensity at 50% _VO2peak , which was
lower than the 65% _VO2max and room temperature condi-
tion set in the previous study [9] because we thought that
the 65% _VO2max intensity under hot condition would be
too strenuous for untrained subjects. To measure rectal
temperature during the exercise, subjects self-inserted a
rectal probe (401 J; Nikkeiso-YSI Co. Ltd., Musashino,
Japan) 10 cm past the anal sphincter. During exercise, mi-
nute ventilation _V E
 
, expired gas concentration, HR, and
rectal temperature were measured for 3 min at the 4-min
(warm-up), 15-min, 30-min, 45-min, 60-min, 75-min, and
90-min time points. Subjects were asked to indicate their
overall RPE, RPE-cardiovascular, and RPE-legs to identify
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time point from the warm-up to the end of the 90-min
cycling exercise.
Following the 90-min exercise, subjects completed
POST that lasted approximately 10 min in the same
condition. Subjects were required to complete a set
amount of work (52.4 [SD, 8.6] kJ) as fast as possible.
The total amount of work to be performed was calculated
using the following formula [30]: Total work (J) = 0.65
Wpeak × 600. Wpeak (134.4 [SD, 22] W) was the maximal
workload capacity determined in preliminary testing and
600 was the duration in seconds (equivalent to 10 min).
The ergometer was connected to a computer that calcu-
lated and displayed the total amount of work performed.
Subjects received only information on the percentage of
work performed relative to the set amount of work from
the examiner. A familiarization trial was also completed
before commencement to allow subjects to familiarize
themselves with the protocol and laboratory setting.
Blood sampling and analysis
Venous blood samples were collected by venipuncture
from an antecubital vein before exercise (PRE); at the
30-min, 60-min, and 90-min time points during the ex-
ercise; and at POST. Blood samples were collected into
serum separation tubes or vacutainers containing ethyl-
enediaminetetraacetic acid (EDTA). A fraction of whole
blood was used to measure hemoglobin, hematocrit, and
full blood cell count. Serum separation tubes were left to
allow blood to clot at room temperature for 30 min, while
vacutainers containing EDTA for plasma separation were
immediately centrifuged at 1,000 × g for 10 min. Serum
and plasma were then removed and stored at −80°C for fu-
ture analysis. Serum free fatty acid and plasma glucose
concentrations, leukocyte concentrations, hemoglobin, and
hematocrit were analyzed by BML, Inc. (Tokyo, Japan).
Commercial enzyme-linked immunosorbent assay (ELISA)
kits were used to measure plasma concentrations of
the cytokines interleukin (IL)-1β, IL-1 receptor antagon-
ist (IL-1ra), IL-6, tumor necrosis factor (TNF)-α (R&D
Systems, Minneapolis, MN), IL-8, IL-10, and IL-12p40
(Becton Dickinson Bioscience, San Diego, CA), and the
neutrophil activation markers myeloperoxidase (MPO)
and calprotectin (HyCult Biotechnology, Uden, the
Netherlands). ELISA measurements were performed ac-
cording to the instructions for each ELISA kit using
a microplate reader (VERSAmax; Molecular Devices,
Sunnyvale, CA). Plasma concentrations of all these vari-
ables were adjusted for changes in plasma volume [31].
Statistical analysis
All data were checked for normal distribution using
the Kolmogorov-Smirnov statistic. Data for rectal tem-
perature, HR, VE, RER, blood glucose, serum free fattyacid, leukocyte concentrations, and performance test
result were normally distributed. Data for serum sex
hormones, IL-8, IL-12p40, and MPO concentrations
were normally distributed after log transformation. Data
for serum IL-1β, IL-1ra, IL-6, IL-10, calprotectin, and
TNF-α concentrations were not normally distributed.
Normally distributed data (sex hormones and POST result
were analyzed using a 2 × 2 factor (menstrual cycle phase ×
beverage) repeated analysis of variance (ANOVA). For
other normally distributed data (rectal temperature, HR,
and RER), a 4 × 8 factor (trial × time) repeated ANOVA
was used to determine trial effects, time effects, and trial ×
time interactions. For other normally distributed data
(blood glucose, free fatty acid, leukocyte concentrations,
IL-8, IL-12p40, and MPO), a 4 × 5 factor (trial × time)
repeated ANOVA was used to determine trial effects,
time effects, and trial × time interactions. When sig-
nificant trial effects, time effects, or trial × time interactions
were evident, Bonferroni posthoc multiple comparisons
were used. Data for serum IL-1β, IL-1ra, IL-6, IL-10,
calprotectin, and TNF-α were analyzed using non-
parametric Friedman’s ANOVA on ranks test to deter-
mine time effects. Kruskal-Wallis’ one-way ANOVA was
used to assess differences between trials at specific time
points. Data were analyzed using SPSS version 19 for
Windows (IBM Corporation, Armonk, NY) with the
threshold for statistical significance set at P = 0.05. Rela-
tionships between dependent variables and leukocyte
concentration were assessed with Pearson product corre-




Table 1 shows the serum estradiol and progesterone
concentrations of all subjects. Menstrual cycle phase ×
beverage did not affect serum estradiol and progesterone
concentrations. A main effect of menstrual cycle phase
(P < 0.01), but not of the beverage, on both hormones
was observed. Serum estradiol and progesterone concen-
trations were significantly higher in the luteal phase than
in the follicular phase [32]. We used the progesterone
concentration limit 5.1 ng/mL for luteal phase verifica-
tion according to previous studies [12,33].
Physiologic response
Rectal temperature data during exercise is shown in
Figure 1.
The results show that menstrual cycle phase and bev-
erage type had significant effect on rectal temperature
during exercise (P < 0.05). Although there was a signifi-
cant difference within a trial, there was no significant
difference between the trials. Rectal temperature was sig-
nificantly increased over time during exercise (P < 0.01).
Table 1 Resting hormone concentration of subjects before each trial
FA LA FC LC
Subject [E] (pg/mL) [P] (ng/mL) [E] (pg/mL) [P] (ng/mL) [E] (pg/mL) [P] (ng/mL) [E] (pg/mL) [P] (ng/mL)
1 33.4 0.2 171.4 18.9 163.7 0.3 321.3 15.7
2 34.8 0.2 125.5 10.4 42.7 0.1 98.5 7.4
3 30.8 0.4 94.0 6.0 39.4 0.2 68.3 5.7
4 47.3 0.1 108.9 6.4 83.8 1.4 171.0 14.9
5 50.6 0.2 201.4 13.2 98.0 0.2 327.4 19.9
6 201.0 0.4 151.2 25.6 44.0 0.4 102.1 9.1
mean 66.3 0.3 142.1 13.4 78.6 0.4 181.4 12.1
SD 66.5 0.1 40.4 7.0 48.3 0.4 115.7 5.1
Abbreviations: FA follicular phase placebo trial, LA luteal phase placebo trial, FC follicular phase carbohydrate trial, LC luteal phase carbohydrate trial. [E], estradiol
concentration, [P] progesterone concentration.
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show that menstrual cycle and beverage type had no sig-
nificant effect on HR, _V E, and RER. However HR and
_V E significantly increased to over time during exercise
(P < 0.01). RER significantly changed over time during ex-
ercise (P < 0.01). Furthermore, there was no significant ef-
fect of menstrual cycle phase or beverage type on RPE data
(data not shown).
The total amount of CHO consumed in the CHO tri-
als (FC and LC) was 40 g. Plasma glucose and free fatty
acid data are shown in Figure 2.
There was no trial × time interaction with respect to
change in glucose; however, there was a main effect in trial
(P < 0.05) and time (P < 0.01). Blood glucose at 90 min
in the LA was significantly lower than that in the LC
(P < 0.05), and a lower trend compared with that in the
FC (P < 0.068).Figure 1 Rectal temperature during cycling exercise. Data are mean ± SE
between the trials (P < 0.05). #Significant repeated-measures ANOVA main effe
follicular phase carbohydrate trial; LA, luteal phase placebo trial; LC, luteal phaThere was a trial × time interaction (P < 0.05), a main
effect in time (P < 0.01), and a trend in trial (P = 0.082)
in serum free fatty acid. The concentration at POST in
the LA was significantly higher compared with that in
the FC (P < 0.01).
Immune response
Leukocyte concentration data are shown in Figure 3.
There was a trial × time interaction (P < 0.01), and a
main effect in trial (P < 0.01) and time in leukocyte con-
centration (P < 0.01). Leukocyte concentration at 90 min
in the LA was significantly higher than that in the FC
(P < 0.01), and that at POST in the LA were significantly
higher than those in the FA (P < 0.05), LC (P < 0.01), and
FC (P < 0.01). Leukocyte concentrations at 90 min in the
LA was higher than those in the FA (P = 0.073) and LC
(P = 0.098). Moreover, leukocyte concentrations at POSTM (n = 6). *Significant repeated-measures ANOVA main effect difference
ct in time (P < 0.01). Abbreviations: FA, follicular phase placebo trial; FC,
se carbohydrate trial; PRE, before exercise.
Table 2 Cardiorespiratory measures during 90 min exercise
Trial 4 min 15 min 30 min 45 min 60 min 75 min 90 min
HR (beat/min) FA 80 ± 50 131 ± 11 138 ± 12 140 ± 12 145 ± 12 149 ± 15 154 ± 15
FC 83 ± 12 134 ± 14 143 ± 17 145 ± 20 148 ± 19 153 ± 21 156 ± 21
LA 82 ± 40 137 ± 90 142 ± 11 149 ± 13 148 ± 18 154 ± 13 156 ± 17
LC 91 ± 16 141 ± 12 149 ± 12 150 ± 12 153 ± 15 154 ± 14 156 ± 14
_VE (L/min) FA 11.1 ± 1.3 28.4 ± 2.4 29.6 ± 3.4 28.4 ± 4.5 29.8 ± 3.8 29.5 ± 3.3 29.8 ± 3.0
FC 10.9 ± 1.0 28.7 ± 2.6 29.5 ± 2.3 28.9 ± 3.1 28.6 ± 2.3 30.0 ± 3.3 30.6 ± 3.5
LA 10.9 ± 2.6 28.9 ± 1.9 30.1 ± 2.4 30.2 ± 4.0 31.0 ± 4.3 32.5 ± 4.9 33.2 ± 6.1
LC 12.1 ± 1.0 29.1 ± 5.4 30.4 ± 3.4 30.5 ± 4.3 30.4 ± 4.5 30.7 ± 4.5 31.9 ± 4.8
RER FA 0.81 ± 0.04 0.88 ± 0.03 0.88 ± 0.03 0.83 ± 0.05 0.84 ± 0.04 0.82 ± 0.04 0.80 ± 0.04
FC 0.83 ± 0.08 0.89 ± 0.04 0.87 ± 0.04 0.83 ± 0.04 0.82 ± 0.04 0.82 ± 0.04 0.81 ± 0.04
LA 0.84 ± 0.05 0.90 ± 0.07 0.89 ± 0.06 0.86 ± 0.08 0.85 ± 0.06 0.85 ± 0.07 0.84 ± 0.08
LC 0.85 ± 0.11 0.89 ± 0.06 0.88 ± 0.05 0.86 ± 0.04 0.85 ± 0.05 0.84 ± 0.05 0.84 ± 0.05
Dates are shown as mean ± SD. Abbreviations: FA follicular phase placebo trial, FC follicular phase carbohydrate trial, IL interleukin, LA luteal phase placebo trial,
LC luteal phase carbohydrate trial, HR heart rate, _V E minute ventilation, RER respiratory exchange rate.
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FC (P < 0.01). Pearson’s correlation coefficient between
serum free fatty acid concentration and leukocyte con-
centration was determined, and a significant positive cor-
relation was found (r = 0.661, P < 0.001).Serum cytokine
concentration data are shown in Table 3.
Serum IL-6 concentrations were significantly higher
at 90 min (P < 0.05) and POST (P < 0.01) from PRE in
3 trials (FA, LA, and LC). Moreover, the concentra-
tions at POST in these 3 trials were significantly higher
(P < 0.01) than those at 30 min. In the FC trial, the con-
centration at POST was significantly higher comparedFigure 2 Blood glucose (A) and serum free fatty acid (B) concentratio
effect difference between the trials (P < 0.05). #Significant repeated-measure
LA and LC (P < 0.05) §Significant repeated-measures ANOVA interaction bet
FC (P < 0.01). Abbreviations: FA, follicular phase placebo trial; FC, follicular p
carbohydrate trial; PRE, before exercise; POST, high intensity time trial perfowith that at PRE and 30 min. However, there were no sig-
nificant differences between the trials at any time point.
Serum MPO concentrations were highest at POST in all
trials. There was a main effect in time (P < 0.01), but no
trial × time interaction or main effect in trial. Serum
calprotectin concentrations were significantly higher
(P < 0.01) at POST from PRE in all 4 trials. The concen-
trations at POST in the FC (P < 0.05), LA (P < 0.01), and
LC (P < 0.05) were higher than those at 30 min. More-
over, the concentrations at 90 min in the FC (P < 0.01),
LA (P < 0.01), and LC (P < 0.05) were significantly higher
than those at PRE.ns. Data are mean ± SEM. *Significant repeated-measures ANOVA main
s ANOVA main effect in time (P < 0.01). aSignificantly different between
ween trial and time (P < 0.05). bSignificantly different between LA and
hase carbohydrate trial; LA, luteal phase placebo trial; LC, luteal phase
rmance test.
Figure 3 Leukocyte concentration during exercise and after
performance test. Data are mean ± SEM. **Significant
repeated-measures ANOVA a trial × time interaction (P < 0.01).
§§Significant repeated-measures ANOVA main effect difference
between the trials (P < 0.01). #Significant repeated-measures ANOVA
main effect difference in time (P < 0.01).aSignificantly different between
LA and FA (P < 0.05). bSignificantly different between LA and LC
(P < 0.01). cSignificantly different between LA and FC (P < 0.01).
dSignificantly different between FA and FC (P < 0.01). Abbreviations:
FA, follicular phase placebo trial; FC, follicular phase carbohydrate trial;
LA, luteal phase placebo trial; LC, luteal phase carbohydrate trial; PRE,
before exercise; POST, high intensity time trial performance test.
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concentrations remained unchanged following the exer-
cise in all 4 trials, and no significant differences were
observed between trials.
Performance test
The mean time (s) required to complete POST was 675
(SD, 163) in the FA, 681 (SD, 147) in the LA, 692
(SD, 156) in the FC, and 678 (SD, 180) in the LC,
respectively. There were no significant differences be-
tween trials. Subjects indicated an RPE of 20 for all
trials at POST.
Discussion
The first purpose of the present study was to investigate
the effect of menstrual cycle phase on immune response
to exercise. The results showed that menstrual cycle
phase affected leukocyte concentrations in response to
prolonged exercise; leukocyte mobilization in the luteal
phase was larger compared to that in the follicular phase
at 90 min of cycling and at POST while ingesting a
placebo beverage. However, there was no significant
effect of menstrual cycle phase on serum cytokine con-
centrations. Thus, these results partially supported our
hypothesis.
The second purpose of this study was to investigate
whether CHO ingestion has an effect on immune response
to prolonged exercise. The results showed that ingesting aCHO beverage attenuated leukocyte mobilization and
eliminated the differences between menstrual cycle phases
observed in the placebo beverage trials. However, there
was no effect of CHO ingestion on serum cytokine concen-
trations, which partially supported our hypothesis.
A previous study showed that there was no significant
difference in total leukocyte concentration between
menstrual cycle phases after 90 min of cycling exercise [9].
The reason for the conflicting results between the previ-
ous and present study may be difference in the range of
progesterone concentrations (10.3 [SD, 8.3] nmol/L) in the
luteal phase. This range indicates that most subjects had a
lower progesterone concentration than the 16 nmol/L
limit, which may have weakened the effect of progesterone
on body temperature [12]. However, the correlation be-
tween Tc and immune response could not be determined
because no information on Tc was available in the previous
study.
It is well known that there is a substantial increase in
leukocyte concentration (mainly neutrophils) during en-
durance exercise, and this increase depends on the in-
tensity and duration of exercise [34]. It has been shown
that the elevation of neutrophils is due to several hor-
mones (e.g., epinephrine, cortisol, growth hormone, and
prolactin) that are known to have immunomodulatory
effects [35]. We hypothesized that higher Tc and poten-
tially increased cardiorespiratory strain in the luteal
phase would result in a disturbance in immune response.
However, the results of this study showed that there
were no significant differences in cardiorespiratory re-
sponses between menstrual cycle phases even though
thermoregulatory response was significantly different
between menstrual cycle phases. Therefore, we thought
that causes other than Tc and cardiorespiratory strain
could increase leukocyte concentrations in the luteal
phase.
Some studies have found that menstrual cycle phase
does indeed affect hormonal and metabolic responses to
exercise [36,37], particularly in a CHO-depleted nutri-
tion state [26,38]. It is possible that high concentrations
of sex hormones in the luteal phase decrease gluconeo-
genesis and blood glucose concentrations, which, in
turn, may lead to an increase in circulating cortisol con-
centrations and leukocytosis. In this study, the blood glu-
cose concentration at 90 min in the LA trial was lower
compared with that in the other trials. Moreover, the high
correlation between serum free fatty acid concentration
and leukocyte concentration may suggest this mechanism.
It is possible that the CHO beverage maintained blood
glucose concentrations and prevented the mobilization of
stress hormones that cause leukocytosis. Thus, the in-
crease in leukocyte concentration in the LA might be due
to the combined effect of exercise and differential sub-
strate metabolism by sex hormones.
Table 3 Serum cytokine concentrations
PRE 30 min 60 min 90 min POST
IL-1β (pg/mL)
FA 0.9 ± 3.0 0.9 ± 2.5 1.0 ± 3.2 0.9 ± 2.8 0.7 ± 2.9
FC 0.9 ± 3.9 1.0 ± 4.9 1.0 ± 3.3 1.2 ± 3.7 1.4 ± 3.3
LA 0.9 ± 3.1 1.0 ± 2.8 0.8 ± 2.8 1.1 ± 3.0 1.1 ± 2.8
LC 1.2 ± 2.5 1.1 ± 2.7 0.9 ± 2.4 1.1 ± 2.7 1.3 ± 2.2
IL-1ra (pg/mL)
FA 186 ± 109 196 ± 131 203 ± 154 256 ± 77 267 ± 130
FC 159 ± 59 173 ± 51 234 ± 95 214 ± 121 212 ± 89
LA 203 ± 103 200 ± 100 202 ± 83 196 ± 61 269 ± 152
LC 234 ± 117 219 ± 138 209 ± 81 224 ± 125 177 ± 115
IL-6 (pg/mL)
FA 0.2 ± 1.5 0.1 ± 1.3 0.6 ± 2.3 2.6 ± 3.9a 6.3 ± 12.9b,d
FC 0.1 ± 0.5 0.2 ± 0.3 0.8 ± 1.5 1.9 ± 3.6 2.9 ± 8.8a,c
LA 0.2 ± 0.2 0.2 ± 0.1 0.5 ± 0.8 1.5 ± 4.0a 2.2 ± 9.2b,d
LC 0.2 ± 0.4 0.2 ± 0.2 0.9 ± 1.2 2.3 ± 2.0a,c 4.0 ± 6.6b,d
IL-8 (pg/mL)
FA 1.2 ± 0.5 1.5 ± 0.5 1.3 ± 0.7 1.7 ± 0.7 2.0 ± 0.9
FC 1.5 ± 0.5 1.3 ± 0.5 1.0 ± 0.4 1.5 ± 0.5 1.4 ± 0.6
LA 0.8 ± 0.4 1.1 ± 0.4 1.2 ± 0.7 1.2 ± 0.4 1.1 ± 0.5
LC 1.1 ± 0.4 1.5 ± 0.6 1.1 ± 0.5 1.6 ± 0.9 1.8 ± 0.7
IL-10 (pg/mL)
FA 5.3 ± 4.1 3.8 ± 3.8 5.1 ± 3.8 4.2 ± 1.6 2.8 ± 2.0
FC 2.6 ± 2.3 3.0 ± 5.0 3.2 ± 1.3 2.5 ± 2.7 2.9 ± 3.2
LA 4.5 ± 8.5 3.3 ± 2.4 3.5 ± 3.2 3.5 ± 3.0 4.9 ± 3.4
LC 3.4 ± 3.5 3.7 ± 3.5 3.9 ± 5.6 3.7 ± 2.4 3.4 ± 2.5
IL-12p40 (pg/mL)
FA 37 ± 8 44 ± 11 36 ± 6 38 ± 9 43 ± 5
FC 29 ± 5 36 ± 4 43 ± 8 27 ± 6 36 ± 6
LA 43 ± 7 37 ± 6 32 ± 4 30 ± 10 35 ± 5
LC 32 ± 8 32 ± 3 33 ± 3 30 ± 3 34 ± 4
Calprotectin (ng/mL)
FA 21 ± 14 26 ± 19 27 ± 24 47 ± 28 95 ± 147b
FC 18 ± 46 21 ± 121 25 ± 137 39 ± 196b 43 ± 267b,c
LA 23 ± 32 42 ± 29 62 ± 67 170 ± 181b 240 ± 117b,d
LC 26 ± 17 40 ± 45 60 ± 53 64 ± 42a 103 ± 276b,c
MPO (ng/mL)
FA 17 ± 2 20 ± 3 20 ± 1 27 ± 4 46 ± 11#
FC 20 ± 5 26 ± 8 25 ± 5 38 ± 13 39 ± 9#
LA 10 ± 2 26 ± 4 24 ± 2 34 ± 3 46 ± 5#
LC 17 ± 2 21 ± 3 19 ± 3 30 ± 7 34 ± 8#
TNF-α (pg/mL)
FA 0.3 ± 0.2 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.4 ± 0.2
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Table 3 Serum cytokine concentrations (Continued)
FC 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.1 0.3 ± 0.1
LA 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
LC 0.3 ± 0.1 0.3 ± 0.1 0.2 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
Data for IL-8, IL-12p40 and MPO are shown as mean ± SEM; data for IL-1β, IL-1ra, IL-6, IL-10, Calprotectin and TNF-α are shown as median ± quartile deviation
aSignificantly different from PRE (P < 0.05). bSignificantly different from PRE (P < 0.01). cSignificantly different from 30 min (P < 0.05). dSignificantly different from
30 min (P < 0.01). #Main effect in time (P < 0.01).
Abbreviations: FA follicular phase placebo trial, FC follicular phase carbohydrate trial, IL interleukin, LA luteal phase placebo trial, LC luteal phase carbohydrate trial,
MPO myeloperoxidase, POST high intensity time trial performance test, PRE before exercise, TNF tumor necrosis factor.
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ported that ingesting CHO during exercise suppresses
the rise in circulating neutrophils, most likely by redu-
cing the secretion of stress hormones that regulate neu-
trophil mobilization by maintaining high blood glucose
[13-15]. The results of this study may support these pre-
vious studies.
Muscle-derived IL-6 appears to be at least partly re-
sponsible for the elevated secretion of cortisol during
endurance exercise. Infusion of recombinant human IL-
6 into resting humans to mimic the exercise-induced
plasma concentrations of IL-6 has been shown to increase
plasma cortisol in a similar manner [35,39]. In this study,
an increase in IL-6 concentration was observed in all trials,
but there were no significant differences between men-
strual cycle phases or CHO ingestion at any time point.
These results suggest that factors other than IL-6 may be
more related to changes in leukocyte concentrations, con-
sistent with a previous study [9].
Most [13,15,17,21,40], but not all, studies [18,41,42]
report that carbohydrate ingestion attenuates plasma
IL-6 concentration following exercise. The increase in
plasma IL-6 concentration observed following all trials in
our study could be due to release of IL-6 from the skeletal
muscle [43,44]. However, consistent plasma IL-6 concen-
tration between trials was most likely due to consistent re-
lease of IL-6 from the skeletal muscle during exercise and
suggests that there was no difference in muscle glycogen
concentration [45].
Elevated serum MPO concentration after exercise likely
reflects neutrophil degranulation because MPO is con-
tained in azurophilic granules within neutrophils. MPO is
an important contributor to neutrophil microbicidal activ-
ity. Serum MPO concentration depends on exercise inten-
sity [46] and temperature [6]. In the present study, serum
MPO concentration was significantly increased at POST
compared with PRE, but there were no significant differ-
ences between trials. In this study, consistent with other
findings [47], CHO intake did not influence change in
serum MPO concentration.
Calprotectin is secreted from monocytes and neutro-
phils in response to a variety of inflammatory conditions
[48]. In the present study, serum calprotectin concentra-
tion was significantly increased at POST compared withPRE, but there were no significant differences between
trials. These results are in agreement with a previous
study, in which the effect of heat stress during exercise
on change in serum calprotectin concentration was re-
ported [6]. The mechanisms regulating calprotectin release
and the biological role of calprotectin during exercise are
currently uncertain. We incorporated the POST in the ex-
perimental protocol assuming that participants would at-
tempt a sprint similar to that in actual competitions. The
study results show that menstrual cycle phase and beverage
type had no significant effect on the timed performance
test. In this study, cardiorespiratory responses were not sig-
nificantly different between trials; therefore, no differences
in performance between trials could be observed. This re-
sult supports a previous study [12], in which menstrual
cycle phase did not affect the endurance performance at
moderate temperatures.
One of the limitations of this study is the absence of
cortisol, growth hormone, catecholamine, and muscle
glycogen measurements during exercise, which would
have allowed a better understanding of the relationships
among hormone concentrations, glucose availability, and
differential leukocyte concentrations. Even though we
found that menstrual cycle phase significantly affected
leukocyte concentration, we cannot rule out the possibil-
ity that the small cohort of subjects used in this study
might have had a negative impact on some of the other
measurements, rendering them non-significant. The
small number of subjects may not have provided ad-
equate statistical power to detect real, but relatively
small, differences in some of the measured variables.
Conclusions
Menstrual cycle phase affected circulating leukocyte con-
centrations during endurance exercise while ingesting a
placebo. The degree of leukocyte mobilization was greater
in the luteal phase compared with the follicular phase.
Ingestion of the CHO beverage eliminated the effect of
menstrual cycle phase on leukocyte concentration, which
may be explained by the effect of sex hormones on sub-
strate utilization. However, there was no effect of men-
strual cycle phase on cytokines during exercise.
The results of this study demonstrate that menstrual
cycle changes do alter leukocyte concentration during
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as the placebo trials progressed, differences became more
pronounced, indicating that as endogenous CHO reserves
were depleted the effect of menstrual cycle changes be-
come more evident. This was further supported by the
absences of difference in immune response between the
FC and LC trials.
In women undergoing endurance training for recre-
ational purposes, prolonged exercise in the luteal phase
may lead to larger immune disturbances compared to
the follicular phase if they ingest water alone during
the duration of the exercise. Therefore, we recommend
ingesting carbohydrate beverages to attenuate immune
disturbances especially in the luteal phase, even though
they are unlikely to enhance test performance. However,
the total subject number is small and does not constitute
a representative sample, and the results need further val-
idation using larger cohorts.
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